Track record
Matthew L. Posard
An officer, director or large holder of 2 blank-check companies. Every role below was declared by Matthew L. Posard in an SEC ownership filing.
Vehicles
2
Still live
0
Closed a deal
2 of 2
Capital involved
$162M
Every vehicle, newest first
- Nautilus Biotechnology, Inc.NAUT · Director · IPO Aug 10, 2020$150MCompleted
- DermTech, Inc.— · Director · IPO Jun 21, 2017$12.4MCompleted
Compiled from Forms 3 and 3/A filed with the SEC under CIK 1543792. Roles are as declared at the time of filing and may have changed since. Nothing here is a judgement about any individual.